In this systematic review and meta-analysis we re-evaluated the treatment effect of IL-6 (receptor) antagonists on mortality and possible side effects in COVID-19 patients compared to COVID-19 patients who did not receive IL-6 (receptor) antagonists2. Here, IL6 is linked to COVID-19.